ACTRN12607000271404已完成1 期
A single centre, double blind, placebo controlled, prospective study to assess the immunogenicity and safety of orally administered killed whole cell non-typeable Haemophilus influenzae (NTHi) HI-1-164 in smokers at risk of recurrent bronchitis (Study HI-H003)
The University of Newcastle Research Associates (TUNRA) Ltd0 个研究点目标入组 64 人开始时间: 2007年5月18日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 64
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 65 Years（—）
- 性别
- All
入选标准
- •Smokers who had smoked at least 10 cigarettes per day for the past 2 years (1 pack year), with no medical or social reason for being unable to comply with requirements of the study, and willingness and ability to give signed informed consent.
排除标准
- •Known current chronic infection (except episodes of acute bronchitis with or without chronic bronchitis); participation in a clinical trial in the past 3 months; pregnant, breast-feeding, or women with child-bearing potential without an effective method of contraception, any patient likely to withdraw or not comply with the study protocol; any other medical reason that the medical advisor feels that a patient should not be included.
研究者
相似试验
已完成
2 期
A clinical trial to study the effects of drugs Calmagen cream and lotion in patients for topical treatment of Tinea (ringworm infection).CTRI/2012/03/002522Biovite Australia Pty Ltd28
进行中（未招募）
1 期
A Single Centre, double blind, placebo controlled, randomised trial to evaluate the efficacy and safety of Simvastatin in the treatment of Psoriasis. - Statin & PsoriasisEUCTR2005-000989-39-GBGuy's & St Thomas NHS foundation Trust
进行中（未招募）
不适用
A study to test if aleglitazar has a positive effect on the heart of patients with Type 2 diabetes and without cardiac disease, looking at the way the heart processes energy and fat.EUCTR2012-001639-29-GBF. Hoffmann-La Roche Ltd
进行中（未招募）
不适用
A single centre, double-blind, randomised, placebo controlled cross-over study to evaluate the efficacy and tolerability of tonabersat in the prophylaxis of migraine in patients presenting with migraine with auraMigraine with aura meeting the diagnostic criteria of the International Classification of Headache Disorders (Edition 2)EUCTR2006-000210-21-DKProf Jes Olesen34
已完成
1 期
A Single dose safety and tolerability study of oral noribogaine in healthy volunteersSafety and tolerability study of oral noribogaine in Healthy Volunteer ParticipantsOther - Research that is not of generic health relevance and not applicable to specific health categories listed aboveACTRN12612000821897DemeRx, Inc.36